Featured Story

UNC scientists develop a new way to prod stem cells into bone

A team led by Janet Rubin at the University of North Carolina School of Medicine recently found a novel method to push stem cells into forming bone.

GC-1 drug shifts bad 'white' fat into good, calorie-burning 'brown' fat in mice

Researchers at Baylor College of Medicine have published animal research that provides some proof that an experimental drug could one day provide a new therapeutic to effectively fight fat by pushing "bad" white fat to become "good" brown fat.

Generic alcoholism drug used to flush dormant HIV

Actually eradicating the virus that causes AIDS has been thwarted by the virus' ability to hide out in dormant cells. Now researchers say that a generic alcoholism drug called disulfiram has demonstrated the ability to wake up the virus and flush it out for destruction.

Bone microenvironment offers new approach on prostate cancer

Studying the bone microenvironment may offer new insights into better drugs for fighting prostate cancer metastasis.

Warp Drive Bio constructs a new cancer R&D tech platform

Cambridge, MA-based Warp Drive Bio is launching a new cancer drug platform which the biotech claims will open up new, previously undruggable targets to developers.


From Our Sister Sites


While working to catch up with other vaccine developers in the race for a respiratory syncytial virus (RSV) vaccine, San Francisco-based Vaxart this week unveiled data demonstrating its candidate's ability to create a "substantial" immune response in a preclinical challenge model.


An FDA warning letter found that for years, Dr. Reddy's Laboratories was testing drug batches in a laboratory that the FDA was never told existed and often shipped to the U.S. products that had repeatedly failed tests for impurities.